Cargando…
Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics
Radiopharmaceutical therapy, which can detect and treat tumours simultaneously, was introduced more than 80 years ago, and it has changed medical strategies with respect to cancer. Many radioactive radionuclides have been developed, and functional, molecularly modified radiolabelled peptides have be...
Autores principales: | Chakraborty, Kushal, Mondal, Jagannath, An, Jeong Man, Park, Jooho, Lee, Yong-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054444/ https://www.ncbi.nlm.nih.gov/pubmed/36986832 http://dx.doi.org/10.3390/pharmaceutics15030971 |
Ejemplares similares
-
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
por: D’Huyvetter, Matthias, et al.
Publicado: (2014) -
Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments
por: Bison, Sander M., et al.
Publicado: (2014) -
Pharmaceutical Aspects of Nanocarriers for Smart Anticancer Therapy
por: Hwang, Seung Rim, et al.
Publicado: (2021) -
Carbon Nanotube and Its Derived Nanomaterials Based High Performance Biosensing Platform
por: Mondal, Jagannath, et al.
Publicado: (2022) -
Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review
por: Conte, Miriam, et al.
Publicado: (2023)